Free Trial

Electromed (ELMD) Competitors

Electromed logo
$19.08 -0.93 (-4.65%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$19.13 +0.05 (+0.27%)
As of 07/11/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELMD vs. CBLL, EMBC, BBNX, BVS, AVNS, RXST, AXGN, KIDS, BFLY, and SMLR

Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include CeriBell (CBLL), Embecta (EMBC), Beta Bionics (BBNX), Bioventus (BVS), Avanos Medical (AVNS), RxSight (RXST), AxoGen (AXGN), OrthoPediatrics (KIDS), Butterfly Network (BFLY), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

Electromed vs. Its Competitors

CeriBell (NASDAQ:CBLL) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

40.8% of Electromed shares are owned by institutional investors. 20.1% of CeriBell shares are owned by company insiders. Comparatively, 14.0% of Electromed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, CeriBell had 11 more articles in the media than Electromed. MarketBeat recorded 11 mentions for CeriBell and 0 mentions for Electromed. CeriBell's average media sentiment score of 0.34 beat Electromed's score of 0.00 indicating that CeriBell is being referred to more favorably in the media.

Company Overall Sentiment
CeriBell Neutral
Electromed Neutral

Electromed has a net margin of 11.34% compared to CeriBell's net margin of 0.00%. Electromed's return on equity of 15.71% beat CeriBell's return on equity.

Company Net Margins Return on Equity Return on Assets
CeriBellN/A N/A N/A
Electromed 11.34%15.71%13.37%

Electromed has lower revenue, but higher earnings than CeriBell.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CeriBell$65.44M8.91-$40.46MN/AN/A
Electromed$61.44M2.60$5.15M$0.7924.15

CeriBell presently has a consensus target price of $32.14, indicating a potential upside of 99.27%. Electromed has a consensus target price of $38.00, indicating a potential upside of 99.16%. Given CeriBell's higher possible upside, research analysts clearly believe CeriBell is more favorable than Electromed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CeriBell
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Summary

CeriBell and Electromed tied by winning 7 of the 14 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELMD vs. The Competition

MetricElectromedElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$160.01M$32.88M$5.56B$20.64B
Dividend YieldN/AN/A5.06%3.72%
P/E Ratio25.443.2328.2627.83
Price / Sales2.60195.05427.7042.22
Price / Cash41.3641.3637.1222.32
Price / Book3.742.058.044.57
Net Income$5.15M-$25.54M$3.19B$989.30M
7 Day Performance-8.18%4.51%3.62%0.20%
1 Month Performance-4.93%33.16%5.98%5.53%
1 Year Performance31.77%128.57%29.39%10.30%

Electromed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELMD
Electromed
0.8705 of 5 stars
$19.08
-4.6%
$38.00
+99.2%
+31.8%$160.01M$61.44M25.44160
CBLL
CeriBell
2.5957 of 5 stars
$17.20
-9.1%
$32.14
+86.9%
N/A$621.61M$65.44M0.00N/ANews Coverage
Insider Trade
EMBC
Embecta
4.7539 of 5 stars
$10.03
-2.8%
$19.33
+92.8%
-20.5%$586.15M$1.12B11.142,100News Coverage
Positive News
BBNX
Beta Bionics
N/A$13.40
-0.9%
$23.44
+75.0%
N/A$580.97M$69.83M0.00294
BVS
Bioventus
2.9823 of 5 stars
$6.82
-2.8%
$13.75
+101.6%
+6.4%$560.22M$567.70M-11.181,200News Coverage
AVNS
Avanos Medical
2.8355 of 5 stars
$11.87
-3.9%
N/A-43.3%$548.87M$687.80M-1.422,227News Coverage
Negative News
RXST
RxSight
2.2444 of 5 stars
$12.43
-4.8%
$37.90
+204.9%
-83.2%$530.31M$148.31M-18.55220Trending News
Analyst Forecast
AXGN
AxoGen
2.4933 of 5 stars
$11.36
+3.9%
$24.50
+115.7%
+43.9%$517.33M$187.34M-75.73450Positive News
High Trading Volume
KIDS
OrthoPediatrics
4.2821 of 5 stars
$21.24
-5.5%
$35.83
+68.7%
-33.2%$515.92M$204.73M-12.14200Positive News
BFLY
Butterfly Network
2.6581 of 5 stars
$1.89
-2.6%
$3.50
+85.2%
+54.7%$467.38M$85.63M-6.52460News Coverage
Positive News
Options Volume
SMLR
Semler Scientific
2.581 of 5 stars
$38.95
-3.7%
$71.00
+82.3%
+35.8%$434.29M$56.29M-14.92120Analyst Forecast

Related Companies and Tools


This page (NYSE:ELMD) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners